Eli Lilly and Co (NYSE:LLY)

139.50
Delayed Data
As of Apr 03
 -2.68 / -1.88%
Today’s Change
101.36
Today|||52-Week Range
147.87
+6.14%
Year-to-Date
Pfizer, Merck, and Eli Lilly Will Pay Their Doctors to Get Back to Treating Patients During the COVID-19 Pandemic
Apr 02 / MotleyFool.com - Paid Partner Content
Better Buy: Geron vs. Acceleron
Mar 27 / MotleyFool.com - Paid Partner Content
Do Clinical Trial Delays Mean Trouble for Pharmaceutical Stocks?
Apr 01 / MotleyFool.com - Paid Partner Content
3 Reasons Pharma Stocks Are a Buy Right Now
Mar 25 / MotleyFool.com - Paid Partner Content
Eli Lilly Licenses Immunology Drugs for Up to $880 Million
Mar 31 / MotleyFool.com - Paid Partner Content
Eli Lilly to Pause Enrollment in Most Drug Trials
Mar 23 / MotleyFool.com - Paid Partner Content
Is Pfizer a Great Stock to Buy During the Coronavirus Market Crash?
Mar 31 / MotleyFool.com - Paid Partner Content
Eli Lilly Will Provide Drive-Through Coronavirus Testing to Indianapolis Healthcare Workers
Mar 22 / MotleyFool.com - Paid Partner Content